Public Reporting

Accountable Care Public Reporting Information

Accountable Care Organization (ACO) Name and Location

Freedom Healthcare Alliance, LLC
8761 Dorchester Road
Suite 230
North Charleston, SC 29420

ACO Primary Contact
Primary Contact Name: Lissa Lara, CEO
Primary Contact Phone Number: 843-412-1590
Primary Contact Email Address:

Organizational Information

Dorchester Medical Associates N
Internal Medicine of Walterboro N
James T Martin Jr, MD N
Lake City Family Medicine, LLC N
Liberty Doctors, LLC N

ACO Governing Body

Member First Name Member Last Name Title/Position Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Lissa Lara CEO 16% Other N/A
Hugh Durrence MD CMO Board Member 13% ACO Participant Representative Liberty Doctors, LLC
Donald Hanna MD Board Member 13% ACO Participant Representative Liberty Doctors, LLC
Douglas Gleaton MD Board Member 13% ACO Participant Representative Liberty Doctors, LLC
John Forney MD Board Member 13% ACO Participant Representative Liberty Doctors, LLC
David Price MD Board Member 6% Medicare Beneficiary Representative N/A
James Martin Jr MD Board Member 13% ACO Participant Representative James T Martin Jr., LLC
Jeffrey Kramer MD Board Member 13% ACO Participant Representative Internal Medicine of Walterboro


Lissa Lara ACO Executive
Hugh Durrence Medical Director
John Park Compliance Officer
Kathrine Hill Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Finance Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
Quality Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
Kathrine Hill, Quality Assurance, Improvement Officer
Compliance Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
John Park, Compliance Officer

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • Primary Care Practice

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Fourth Agreement Period
    • Performance Year 2022, $ 3,429,097.03

Shared Savings Distribution:

  • Fourth Agreement Period
    • Performance Year 2022
    • Proportion invested in infrastructure: 19.5%
    • Proportion invested in redesigned care processes/resources: 6%
    • Proportion of distribution to ACO participants: 74.5%

Quality Performance Results

2022 Quality Performance Results:

Quality performance results are based on CMS Web Interface

Measure # Measure Name Collection Type Rate ACO Mean

Quality ID# 321




CAHPS for MIPS Survey


Measure# 479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups

Administrative Claims


0.1454 0.1510
Measure# 484 Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC)

Administrative Claims


25.78 30.97

Quality ID# 318


Falls: Screening for Future Fall Risk


CMS Web Interface


85.05 87.83

Quality ID# 110


Preventive Care and Screening: Influenza Immunization


CMS Web Interface


61.69 77.34

Quality ID# 226


Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention


CMS Web Interface


52.94 79.27

Quality ID# 113


Colorectal Cancer Screening


CMS Web Interface


63.18 75.32
Quality ID# 112 Breast Cancer Screening

CMS Web Interface


67.82 78.07

Quality ID# 438


Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS Web Interface


83.48 86.37

Quality ID# 370


Depression Remission at Twelve Months CMS Web Interface 5.36 16.03
Quality ID# 001 Diabetes: Hemoglobin A1c  (HbA1c) Poor Control CMS Web Interface 11.85 10.71
Quality ID# 134

Preventive Care and Screening: Screening for Depression and Follow-up Plan


CMS Web Interface 77.82 76.97
Quality ID# 236 Controlling High Blood Pressure CMS Web Interface 69.19 76.16

For previous years’ Financial and Quality Performance Results, please visit:

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

 Fraud and Abuse Waivers

      ACO Participation Waiver:
        The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.
          Parties to the arrangement: Freedom Health Alliance, LLC and Laboratory Corporation of America Holdings
          Date of arrangement: Dec.1, 2022
          Items, services, goods, or facility provided: Grants to incorporate data analytics platforms to facilitate care coordination and promote outcomes of care. Incorporate Lab Corp’s lab data into clinical data to provide a more robust view of the ACO’s patient population.
            Date and nature of any amendments to the arrangement, if applicable: January 1, 2024, Renewal Agreement.